Researchers who analyzed the DNA of 280 patients with prostate cancer found that those who had abnormal levels of disturbances at chromosomal sites that are susceptible to DNA damage had a higher risk of cancer relapse, suggesting treatment failure. If validated in larger studies, the results could lead to the development of a test to help determine the best course of treatment.
Genetic characteristics may help predict prostate cancer treatment response
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||